fetching data ...

OP0302 (2024)
CLONAL SHARING OF CD8+ T-CELLS LINKS SKIN AND JOINT INFLAMMATION IN PSORIATIC ARTHRITIS
Keywords: Adaptive immunity, '-omics
L. Durham1, F. Humby2, N. Ng2, S. Ryan1, R. Nuamah3, K. Fung3, A. Menon3, P. Dhami3, B. Kirkham2, L. Taams1
1King’s College London, Centre for Inflammation Biology and Cancer Immunology, London, United Kingdom
2Guy’s and St Thomas’ NHS Foundation Trust, Rheumatology Department, London, United Kingdom
3Guy’s and St Thomas’ NHS Foundation Trust, Genomics Facility, London, United Kingdom

Background: Type-17 CD8+ tissue resident memory (T RM ) cells are enriched in the skin in psoriasis and in the joints in psoriatic arthritis (PsA) pointing to a key role for these cells in driving inflammation in both sites. We hypothesised that PsA is an antigen driven, tissue resident, IL-17+ CD8+ T cell mediated disease and that skin and synovial tissue inflammation is linked in terms of CD8+ T cell clonality and phenotype.


Objectives: The objectives of this study were 1) To determine whether synovial fluid (SF) is an appropriate proxy for investigating the inflammatory T cell infiltrate in synovial tissue (ST) in inflammatory arthritis; and 2) To compare the T cell receptor (TCR) repertoire and phenotype of T cells from paired samples of skin and ST and/or SF from patients with PsA.


Methods: Memory (CD45RA-CD27±and CD45RA+CD27-) T cells were sorted from paired samples of blood, skin epidermis, synovial fluid (SF) and synovial tissue (ST) from patients with PsA (n=7) and from blood, SF and ST from patients with RA (n=1) for 5’ single cell RNA and TCR sequencing.


Results: Comparison of SF and ST T cells from 6 patients (n=5 PsA, n=1 RA) revealed striking similarities in the TCR repertoires in SF and ST, particularly for CD8+ T cells. Furthermore, once artefact arising from collagenase digestion had been accounted for, the frequencies of T cell subsets were similar in SF and ST. These data indicate that SF is an appropriate proxy to investigate the T cell infiltrate in ST in inflammatory arthritis. Comparison of T cells from paired skin and ST and/or SF from 6 patients with PsA revealed an enrichment of type-17 CD8+ TRM cells in both sites. However, there were phenotypic differences between the two sites including a stronger IL-17 signature in the skin compared to increased expression of GZMK (encoding granzyme K) in the joint. Importantly, several T cell clones were shared between the skin and the joint. Across the six patients 155 CD8+ T-cell clones were shared between the two sites, comprising 1,071 CD8+ T cells and taking up a median of 13% of the skin and 8% of the joint CD8+ TCR repertoire. In the CD4+ T cell compartment there were 46 skin-joint shared clones, comprising 130 cells and taking up 6% of the skin and 1% of the joint TCR repertoire. CD8+ skin-joint shared clones tended to have a similar phenotype at both sites, characterised by increased expression of genes associated with a cytotoxic, tissue-resident phenotype.


Conclusion: Whilst there were phenotypic differences between T cells from the skin and the joint in PsA, T cells expressing identical TCRs and with similar phenotypes were present in both sites. Skin-joint shared clones had increased expression of cytotoxic genes suggesting that they were more activated and pro-inflammatory than their non-shared counterparts. Collectively these data indicate that in PsA the T cell infiltrate in the skin and joint is linked in terms of T cell clonality and raises the possibility that T cells migrate between the skin and the joint to propagate inflammation across both sites.


REFERENCES: NIL.


Acknowledgements: Supported by MRC and NIHR-BRC at KCL/GSTT.


Disclosure of Interests: Lucy Durham is currently funded by an MRC-AstraZeneca Industry Partnership fellowship, Frances Humby: None declared, Nora Ng: None declared, Sarah Ryan: None declared, Rosamond Nuamah: None declared, Kathy Fung: None declared, Athul Menon: None declared, Pawan Dhami: None declared, Bruce Kirkham: None declared, Leonie Taams has received research grant funding from Sanofi.


DOI: 10.1136/annrheumdis-2024-eular.3932
Keywords: Adaptive immunity, '-omics
Citation: , volume 83, supplement 1, year 2024, page 112
Session: Clinical Abstract Sessions: How modern technology helps us understand SpA & PsA (Oral Abstract Presentations)